Cargando…
Development of a radiolabeled site-specific single-domain antibody positron emission tomography probe for monitoring PD-L1 expression in cancer
Despite advances in immunotherapy for the treatment of cancers, not all patients can benefit from programmed cell death ligand 1 (PD-L1) immune checkpoint blockade therapy. Anti-PD-L1 therapeutic effects reportedly correlate with the PD-L1 expression level; hence, accurate detection of PD-L1 express...
Autores principales: | Chen, Yinfei, Zhu, Shiyu, Fu, Jiayu, Lin, Jianguo, Sun, Yan, Lv, Gaochao, Xie, Minhao, Xu, Tao, Qiu, Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Xi'an Jiaotong University
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805943/ https://www.ncbi.nlm.nih.gov/pubmed/36605578 http://dx.doi.org/10.1016/j.jpha.2022.09.001 |
Ejemplares similares
-
Rational design of caspase-responsive smart molecular probe for positron emission tomography imaging of drug-induced apoptosis
por: Qiu, Ling, et al.
Publicado: (2019) -
Peptide-based positron emission tomography probes: current strategies for synthesis and radiolabelling
por: Failla, Mariacristina, et al.
Publicado: (2023) -
Radiolabelled Peptides for Positron Emission Tomography and Endoradiotherapy in Oncology †
por: Rangger, Christine, et al.
Publicado: (2020) -
Synthesis and Biological Evaluation of a Radiolabeled PET (Positron Emission Tomography) Probe for Visualization of In Vivo α-Fucosidase Expression
por: Cotton, Jonathan, et al.
Publicado: (2021) -
(11)C-radiolabeled aptamer for imaging of tumors and metastases using positron emission tomography- computed tomography
por: Ozerskaya, Anastasia V., et al.
Publicado: (2021)